Bottom line
Is IQSI a good fund? The bottom line
IQSI is a managed international stock ETF from New York Life Investments.
Its expense ratio is 0.15% — about $15 a year on every $10,000 invested, cheaper than 95% of international stock funds we track.
It returned +27.1% over one year, +8.3% a year over five years (as of Dec 31, 2025, per its prospectus).
With $268 million in net assets and 588 holdings, its largest position is Asml Holding Nv (4.6%) and the top 10 make up 19.3% of the portfolio.
The closest lower-cost alternative we found is FIONX (0.035%, 60% top-holdings overlap).
What stands out
- Low cost: cheaper than 95% of international stock peers
- Broadly diversified (588 holdings)
Updated Nov 19, 2026
What IQSI invests in
The Fund seeks investment results that track (before fees and expenses) the price and yield performance of its underlying index, the NYLIM Candriam International Equity Index (the Underlying Index).
The Fund employs a passive management or indexing investment approach designed to track the performance of the Underlying Index. The Advisor is the index provider for the Underlying Index and Candriam serves as the index consultant to the Advisor for the Underlying Index. The Underlying Index is designed to deliver exposure to equity securities of companies meeting environmental, social and corporate governance (ESG) criteria developed by Candriam and weighted using a market-capitalization weighting methodology. The Fund will, under normal circumstances, invest at least 80% of its assets (net assets, plus the amount of any borrowings for investment purposes) in the investments included in its Underlying Index. As of June 30, 2026, the market capitalization range of the Underlying Index was approximately $1.7 billion to $759 billion. As of June 30, 2026, the primary sectors within the…
From the fund's prospectus (filed Aug 26, 2026).
IQSI performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| IQSI | +27.1% | +8.3% | — |
| International Stock median | +25.5% | +6.4% | +7.6% |
Source: Fund prospectus, as of Dec 31, 2025
What IQSI costs
On a $10,000 investment, IQSI's 0.15% expense ratio costs about $15 a year. The prospectus estimates $192 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.
IQSI top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Asml Holding Nv ASML | 4.58% |
| 2 | Roche Holding Ag ROP | 2.14% |
| 3 | Novartis Ag NOVN | 2.02% |
| 4 | Nestle' Sa/ag NESN | 1.88% |
| 5 | Astrazeneca Plc AZN | 1.76% |
| 6 | Siemens Ag SIE | 1.59% |
| 7 | Commonwealth Bank Of Australia CBA | 1.46% |
| 8 | Toyota Motor Corp 7203 | 1.42% |
| 9 | Schneider Electric Se SU | 1.22% |
| 10 | Sap Se SAP | 1.22% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 19.3% of the fund. See all top 25 holdings and asset mix →
Alternatives to IQSI
| Family | Fund | Expense ratio | Overlap | |
|---|---|---|---|---|
| Fidelity | FIONX Fidelity SAI International Index Fund | 0.035% | 60% | Compare |
| Schwab | SWISX Schwab International Index Fund | 0.06% | 55% | Compare |
| J.P. Morgan | BBIN JPMorgan BetaBuilders International… | 0.07% | 62% | Compare |
| iShares | ESGD iShares ESG Aware MSCI EAFE ETF | 0.2% | 68% | Compare |
| SPDR (State Street) | EFAX State Street(R) SPDR(R) MSCI EAFE… | 0.2% | 63% | Compare |
| T. Rowe Price | PIEQX T. Rowe Price International Equity… | 0.25% | 52% | Compare |